Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.
about
Progress towards gene therapy for cystic fibrosisEfficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectorsAdeno-associated virus for cystic fibrosis gene therapyStructural Insights into Adeno-Associated Virus Serotype 5Barriers to inhaled gene therapy of obstructive lung diseases: A reviewOptimization of Streptomyces bacteriophage phi C31 integrase system to prevent post integrative gene silencing in pulmonary type II cells.Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro.In utero lung gene transfer using adeno-associated viral and lentiviral vectors in mice.Attenuation of monocrotaline-induced pulmonary hypertension by luminal adeno-associated virus serotype 9 gene transfer of prostacyclin synthaseBALB/c mice show impaired hepatic tolerogenic response following AAV gene transfer to the liver.Riboswitch-mediated Attenuation of Transgene Cytotoxicity Increases Adeno-associated Virus Vector Yields in HEK-293 Cells.Sorting of transgenic secretory proteins in rhesus macaque parotid glands after adenovirus-mediated gene transfer.Novel adeno-associated viruses derived from pig tissues transduce most major organs in mice.Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1AAV5-mediated gene transfer to the parotid glands of non-human primatesRecent developments in adeno-associated virus vector technology.Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered.Current status of gene therapy for inherited lung diseasesImmunological hurdles to lung gene therapy.Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia.Gene therapy progress and prospects: gene therapy of lysosomal storage disorders.Assessment of the safety and biodistribution of a regulated AAV2 gene transfer vector after delivery to murine submandibular glandsUnique biologic properties of recombinant AAV1 transduction in polarized human airway epithelia.Species-specific differences in mouse and human airway epithelial biology of recombinant adeno-associated virus transduction.Advances in AAV-mediated gene transfer for the treatment of inherited disorders.Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advancesGene therapy for cystic fibrosis: an example for lung gene therapy.Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).Intracellular trafficking of adeno-associated viral vectors.Intranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaquesLack of repeat transduction by recombinant adeno-associated virus type 5/5 vectors in the mouse airwayPseudotyped adeno-associated virus 2/9-delivered CCL11 shRNA alleviates lung inflammation in an allergen-sensitized mouse model.Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epitheliaAlleviation of lung inflammatory responses by adeno-associated virus 2/9 vector carrying CC10 in OVA-sensitized miceAAV-mediated gene transfer for retinal diseases.Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics.Lentivirus vector can be readministered to nasal epithelia without blocking immune responsesFluorescently tagged laminin subunits facilitate analyses of the properties, assembly and processing of laminins in live and fixed lung epithelial cells and keratinocytes.Analysis of adeno-associated virus progenitor cell transduction in mouse lung.Postentry processing of recombinant adeno-associated virus type 1 and transduction of the ferret lung are altered by a factor in airway secretions.
P2860
Q22306014-AE5A861B-BF9F-45A8-BC46-B1E62B77B51BQ24538483-8EC364E8-DC32-4BFC-9416-260B3A361BA5Q26823156-FFA3FCDE-80B0-472C-8EF7-A020ABBFA16AQ27679454-19872959-CB03-4C14-AA3C-082A9A6AC867Q29248141-CF296A4C-F325-46B8-AFE8-0359FA8FAAFAQ33575791-3615ECD0-4397-44F1-8E61-715157657C65Q33713277-AE616C4C-1D25-43CF-8714-A91495A95F0FQ33768129-660060E2-8B8C-4FF5-916B-753C9714A1C6Q33782838-5C9A1A0C-D9D0-4BDA-844F-C5FE73BBD2BBQ33822204-CB45E615-E66F-4256-9449-A30E2920846BQ34044390-D33177F1-8BEF-4159-8FF7-5DE93D1B1314Q34132125-1E47A6C3-5B6D-4E26-A64A-0C21EA336137Q34384998-45E5F2D6-A162-452E-A284-0643E11860AFQ34434903-36302552-2F8D-4C77-9F8D-6D3E0ED383DAQ34470293-9D8ACC83-9A2A-40E9-9732-4A4D7C858DF2Q34775483-D4DEE5BB-8C78-4C5B-B72A-14692A23247CQ35016463-4730B6A8-49FE-49DF-B67C-2117297B6163Q35043830-CF16A8F5-746C-45A4-8394-BB4D683542B5Q35091006-AADF3DAA-070B-4099-AC42-50C721C99725Q35150199-B7037384-CEC7-498A-AFE3-C56BEC85D490Q35186114-EA08DB52-DF0D-428C-BB8E-71FDB6AB54B3Q35188510-824DA553-97CB-4D67-BDC2-E92CF47AD0F7Q35239472-B27DF515-61BC-4053-AB64-C5CA79880DA1Q35546541-6380CE5A-3933-49EA-BCA6-F4491FB31CFAQ35628533-E2D97AE4-F988-468B-8FC3-C74BB80284E5Q35847178-3317169D-71C4-490A-B853-1A84D3D80435Q35904424-CF49D93B-0671-42CF-9E33-80FF159B6FB9Q35904461-236F55C8-1631-4574-8221-35DD4B077EEEQ36097743-DF6830F0-DEAE-441F-B5A1-005538CB3A7AQ36114234-C73F8F29-352C-4D69-9E1C-E38F118D052DQ36315561-69BCCE41-16CE-475F-87D5-6C88F81DBEF6Q36401352-49B7A5F1-FC6D-4AB9-8DBF-88B4F45AB3AEQ36509719-62C25653-7799-4103-9DB4-9E53AF1E40B5Q36562646-2AD55634-8229-4D2A-9E0B-C37BB369899EQ36708300-F070BA5C-8F30-4968-8317-DCF198E1B98FQ36853653-6EA61315-8232-4D86-9923-2F6AFAEBCC4EQ36949698-DAC33E89-AC07-4710-A63A-CDC3F3EBA6A4Q36981816-D6607198-FF49-4A83-B1EF-23BA820F6187Q37149675-1C19A2C2-2B62-47CE-B21A-463FB555148CQ37158813-D2A2A9C4-2074-4FE5-AB00-7FF9A9425B9C
P2860
Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.
@ast
Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.
@en
Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.
@nl
type
label
Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.
@ast
Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.
@en
Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.
@nl
prefLabel
Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.
@ast
Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.
@en
Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.
@nl
P2093
P2860
P1476
Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins
@en
P2093
Alberto Auricchio
Erin O'Connor
Guang-Ping Gao
Markus Hildinger
Roberto Calcedo
P2860
P304
P356
10.1172/JCI0215780
10.1172/JCI15780
P407
P577
2002-08-01T00:00:00Z